Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Serina Therapeutics, Inc. SER

Set alert

Price alert · SER

All alert types
1.94 USD +0.05 +2.65%

At close · Oct 30

1.95 +0.01 +0.52%

After hours · Oct 30, 7:23 PM ET

Bid
1.86 × 100
Ask
1.94 × 100
1.69 Day range 2.50
1.28 52-week range 5.00
YTD
+1.57%
1 year
-59.50%
Open
1.47
Prev close
1.89
Mkt cap
49.28M
Vol
155.11K
Avg vol
67.75K
EPS
-1.87
P/E
0.00
Div yield
0.00%
More statistics
Low
1.69
High
2.50
Forward P/E
0.00
Beta
0.00
Short ratio
1.96
Inst. own
3.37%
Dividend
0.00
Ex-div date
50-d avg
5.80
200-d avg
8.47
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SER has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-3.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -1.0×
FY 2016: -6.4×FY 2017: -15.0×FY 2018: -14.1×FY 2019: -5.7×FY 2020: -5.4×FY 2021: -66.0×FY 2022: -7.9×FY 2023: 21.8×FY 2024: -3.3×FY 2025: -1.0×
FY 2016 5y median -3.3× FY 2025
P/S 0.0×
FY 2016: 59.2×FY 2017: 70.2×FY 2018: 75.9×FY 2019: 39.9×FY 2020: 1077×FY 2021: 12.1×FY 2022: 42.5×FY 2023: 36.7×FY 2024: 658×FY 2025: 0.0×
FY 2016 5y median 36.7× FY 2025
P/B -526×
FY 2016: -4.2×FY 2017: 13.5×FY 2018: 14.2×FY 2019: 31.1×FY 2020: -11.4×FY 2021: -3.5×FY 2022: -1.2×FY 2023: -3.6×FY 2024: 57.5×FY 2025: -526×
FY 2016 5y median -3.5× FY 2025
P/FCF -1.1×
FY 2016: -11.7×FY 2017: -15.7×FY 2018: -10.7×FY 2019: -6.4×FY 2020: -7.4×FY 2021: -17.8×FY 2022: -10.2×FY 2023: -38.8×FY 2024: -2.1×FY 2025: -1.1×
FY 2016 5y median -10.2× FY 2025
EV/EBITDA -0.9×
FY 2016: -8.3×FY 2017: -11.8×FY 2018: -13.8×FY 2019: -6.1×FY 2020: -7.3×FY 2021: -44.4×FY 2022: -14.9×FY 2023: 18.8×FY 2024: -3.2×FY 2025: -0.9×
FY 2016 5y median -3.2× FY 2025
EV/Sales 0.0×
FY 2016: 59.0×FY 2017: 65.0×FY 2018: 71.1×FY 2019: 39.6×FY 2020: 1184×FY 2021: 15.7×FY 2022: 77.5×FY 2023: 35.4×FY 2024: 598×FY 2025: 0.0×
FY 2016 5y median 35.4× FY 2025
FCF Yield -92.3%
FY 2016: -8.6%FY 2017: -6.4%FY 2018: -9.3%FY 2019: -15.7%FY 2020: -13.5%FY 2021: -5.6%FY 2022: -9.8%FY 2023: -2.6%FY 2024: -46.5%FY 2025: -92.3%
FY 2016 5y median -9.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 45.3%FY 2017: 51.2%FY 2018: 39.8%FY 2019: 42.2%FY 2020: -2272.2%FY 2021: -9.6%FY 2022: 100.0%FY 2023: 97.1%FY 2024: -246.4%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -764.6%FY 2017: -599.5%FY 2018: -748.2%FY 2019: -726.8%FY 2020: -19272.2%FY 2021: -47.1%FY 2022: -454.1%FY 2023: -99.2%FY 2024: -30442.9%FY 2025: 0.0%
FY 2016 5y median -99.2% FY 2025
Net Margin 0.0%
FY 2016: -929.9%FY 2017: -468.7%FY 2018: -537.4%FY 2019: -703.4%FY 2020: -20120.4%FY 2021: -36.5%FY 2022: -536.4%FY 2023: 167.1%FY 2024: -19894.6%FY 2025: 0.0%
FY 2016 5y median -36.5% FY 2025
ROE 51843.2%
FY 2016: 66.2%FY 2017: -90.4%FY 2018: -100.7%FY 2019: -548.0%FY 2020: 212.4%FY 2021: 10.7%FY 2022: 15.6%FY 2023: -16.3%FY 2024: -1738.1%FY 2025: 51843.2%
FY 2016 5y median 10.7% FY 2025
ROIC -709.0%
FY 2016: 56.9%FY 2017: -101.2%FY 2018: -126.9%FY 2019: -274.6%FY 2020: -1079.6%FY 2021: -122.9%FY 2022: -280.6%FY 2023: -41.4%FY 2024: -391.2%FY 2025: -709.0%
FY 2016 5y median -280.6% FY 2025
ROA -276.0%
FY 2016: -480.7%FY 2017: -68.3%FY 2018: -70.3%FY 2019: -163.3%FY 2020: -276.8%FY 2021: -40.1%FY 2022: -82.8%FY 2023: 58.8%FY 2024: -165.7%FY 2025: -276.0%
FY 2016 5y median -82.8% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: -15.7%FY 2018: -0.6%FY 2019: 23.8%FY 2020: -96.9%FY 2021: 6316.2%FY 2022: -85.6%FY 2023: 530.6%FY 2024: -98.2%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -40.9%
FY 2016: 0.0%FY 2017: 33.9%FY 2018: -24.1%FY 2019: -20.2%FY 2020: 17.1%FY 2021: 84.3%FY 2022: -39.2%FY 2023: -37.8%FY 2024: -444.8%FY 2025: -40.9%
FY 2016 FY 2025
EPS (diluted) -26.5%
FY 2016: 0.0%FY 2017: 57.5%FY 2018: -17.0%FY 2019: -51.7%FY 2020: 11.6%FY 2021: 94.2%FY 2022: -322.0%FY 2023: 125.3%FY 2024: -339.7%FY 2025: -26.5%
FY 2016 FY 2025
Free Cash Flow -4.6%
FY 2016: 0.0%FY 2017: 25.6%FY 2018: -57.3%FY 2019: -9.2%FY 2020: 27.4%FY 2021: 69.9%FY 2022: 11.6%FY 2023: -42.9%FY 2024: -475.8%FY 2025: -4.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 0.0×FY 2017: 5.8×FY 2018: 3.2×FY 2019: 1.2×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 5.4×FY 2024: 2.4×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 1.7×
FY 2016: 0.0×FY 2017: 5.8×FY 2018: 3.2×FY 2019: 1.2×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 5.4×FY 2024: 2.4×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Debt / Equity -5.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.9×FY 2020: -1.2×FY 2021: -1.1×FY 2022: -1.1×FY 2023: -0.1×FY 2024: 0.4×FY 2025: -5.3×
FY 2016 5y median -1.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.0×FY 2017: 1.0×FY 2018: 0.9×FY 2019: 0.0×FY 2020: -0.7×FY 2021: -10.3×FY 2022: -6.7×FY 2023: -0.7×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median -0.7× FY 2025
Interest Coverage -113×
FY 2016: -510×FY 2017: -701×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -25.8×FY 2021: -527×FY 2022: -143×FY 2023: -5.6×FY 2024: -32.4×FY 2025: -113×
FY 2016 5y median -113× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31